We recommend the Director of OWCP establish internal controls that identify prescription drugs payment and management issues in near-real-time, including: a. reviewing all system data fields provided by PBM(s) and bill pay vendor(s); b. determining any additional data fields/elements needed to monitor pharmaceutical spending and track trends over time; c. ensuring a recurring process to receive and immediately review data from the PBM(s) and bill pay vendor(s); and d. using that data review to report regularly to management, medical director, and staff pharmacists for collaborative identification of current and emerging issues.